JT
GPCR icon

Jupiter Topco’s Structure Therapeutics GPCR Stock Holding History

Jupiter Topco’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279M Buy
+5,204,212
New +$230M 0.11% 173

Other funds holding GPCR

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $23B AUM 48.97% 1-Year Est. Return

Jupiter Topco's GPCR Position: Q2 2026 in Review

Jupiter Topco opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 5,204,212 shares worth $279M. The stake represents 0.11% of the portfolio and ranks #173 among its holdings.

173 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Jupiter Topco held 5,204,212 shares of Structure Therapeutics worth $279M as of Q2 2026.
  • Structure Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Structure Therapeutics made up 0.11% of Jupiter Topco's portfolio in Q2 2026, its #173 holding.
  • 173 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.